RecruitingPhase 1NCT05487807

Adapting and Evaluating a Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia

Quit4Life+: Adapting and Evaluating a Phone-Based Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia (Quit4Life+ )


Sponsor

University of Southern California

Enrollment

800 participants

Start Date

Sep 13, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This proposal tests the efficacy of a phone-based tobacco cessation intervention for people living with HIV (PLWH) in comparison to the standard of care (brief advice to quit) and nicotine replacement therapy (nicotine patches) in Uganda and Zambia. This study will provide insight into the efficacy, feasibility, applicability, and affordability of delivering tobacco cessation interventions through health care professionals at HIV treatment centers in two countries with different tobacco use patterns, policy environments, and health care resources. The previously tested SMS-platform to be used in this study is uniquely positioned to be scaled in low- and middle-income countries worldwide, in which case rigorous research showing even modest success in reducing the prevalence of tobacco consumption among PLWH could confer substantial health and economic benefits.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • \-

Exclusion Criteria7

  • Females who are pregnant, planning to get pregnant, or breastfeeding
  • \<18 years (underage of consent)
  • Visitor, not receiving continuous care at study site
  • Not a current daily tobacco user
  • Any physical, cognitive, or psychological disabilities that would prevent them from participating in the study
  • Illiterate in English and/or local languages
  • Does not consent

Interventions

DRUGNicotine patch

Will be receiving nicotine therapy

BEHAVIORALtext messaging

Will be enrolled in an texting app


Locations(2)

Makerere University

Kampala, Uganda

University of Zambia

Lusaka, Zambia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05487807


Related Trials